nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0203	0.0203	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0202	0.0202	CbGpPWpGaD
Dicyclomine—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.02	0.02	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0189	0.0189	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0187	0.0187	CbGpPWpGaD
Dicyclomine—CHRM1—Monoamine GPCRs—HTR2A—narcolepsy	0.012	0.012	CbGpPWpGaD
Dicyclomine—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.012	0.012	CbGpPWpGaD
Dicyclomine—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—HCRTR2—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—HCRTR1—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Dicyclomine—CHRM1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Dicyclomine—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00998	0.00998	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00987	0.00987	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00987	0.00987	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00984	0.00984	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00984	0.00984	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00953	0.00953	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0095	0.0095	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.00906	0.00906	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.00903	0.00903	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00853	0.00853	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00853	0.00853	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0085	0.0085	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0085	0.0085	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00842	0.00842	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00842	0.00842	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00824	0.00824	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00821	0.00821	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00813	0.00813	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0081	0.0081	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00808	0.00808	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00731	0.00731	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00731	0.00731	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00728	0.00728	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00728	0.00728	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00721	0.00721	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00721	0.00721	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00706	0.00706	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00704	0.00704	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00697	0.00697	CbGpPWpGaD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00696	0.00696	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00687	0.00687	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00685	0.00685	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00664	0.00664	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00614	0.00614	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00612	0.00612	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.006	0.006	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00598	0.00598	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00592	0.00592	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00569	0.00569	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00555	0.00555	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00555	0.00555	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00536	0.00536	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00535	0.00535	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00533	0.00533	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00531	0.00531	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00528	0.00528	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00499	0.00499	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00499	0.00499	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00497	0.00497	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00497	0.00497	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00495	0.00495	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00471	0.00471	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00459	0.00459	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00453	0.00453	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00449	0.00449	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00446	0.00446	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00446	0.00446	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00406	0.00406	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00402	0.00402	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00399	0.00399	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00394	0.00394	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00346	0.00346	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00345	0.00345	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0033	0.0033	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0033	0.0033	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.003	0.003	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.003	0.003	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.003	0.003	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CHKB—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CHKB—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00163	0.00163	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CPT1B—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CPT1B—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000921	0.000921	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000918	0.000918	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000909	0.000909	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000855	0.000855	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000853	0.000853	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000844	0.000844	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000777	0.000777	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000774	0.000774	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000767	0.000767	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000763	0.000763	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000763	0.000763	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.00076	0.00076	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.00076	0.00076	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000753	0.000753	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000753	0.000753	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000459	0.000459	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000457	0.000457	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000453	0.000453	CbGpPWpGaD
